Differential sequences of exosomal NANOG DNA as a potential diagnostic cancer marker

PLoS One. 2018 May 22;13(5):e0197782. doi: 10.1371/journal.pone.0197782. eCollection 2018.

Abstract

NANOG has been demonstrated to play an essential role in the maintenance of embryonic stem cells, and its pseudogene, NANOGP8, is suggested to promote the cancer stem cell phenotype. As the roles of these genes are intimately involved with glioblastoma multiforme progression and exosomes are critical in intercellular communication, we conducted a detailed analysis of the association of the NANOG gene family with exosomes to identify diagnostic markers for cancer. Exosomes were precipitated from conditioned culture media from various cell lines, and NANOG gene fragments were directly amplified without DNA isolation using multiple primer sets. The use of the enzymes AlwNI and SmaI with restriction fragment length polymorphism analysis functioned to distinguish NANOGP8 from other NANOG family members. Collectively, results suggest that the NANOG DNA associated with exosomes is not full length and that mixed populations of the NANOG gene family exist. Furthermore, sequence analysis of exosomal DNA amplified with a NANOGP8 specific primer set frequently showed an insertion of a 22 bp sequence into the 3' UTR. The occurrence rate of this insertion was significantly higher in exosomal DNA clones from cancer cells as compared to normal cells. We have detected mixed populations of NANOG DNA associated with exosomes and have identified preferential modulations in the sequences from cancer samples. Our findings, coupled with the properties of exosomes, may allow for the detection of traditionally inaccessible cancers (i.e. GBM) through minimally invasive techniques. Further analysis of exosomal DNA sequences of NANOG and other embryonic stemness genes (OCT3/4, SOX2, etc.) may establish a robust collection of exosome based diagnostic markers, and further elucidate the mechanisms of cancer formation, progression, and metastasis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3' Untranslated Regions
  • Biomarkers, Tumor / genetics
  • Brain Neoplasms / genetics*
  • Cell Line, Tumor
  • Coculture Techniques
  • Culture Media, Conditioned / pharmacology
  • Exosomes / genetics*
  • Gene Expression Regulation, Neoplastic
  • Glioblastoma / genetics*
  • HEK293 Cells
  • Humans
  • Multigene Family
  • Mutagenesis, Insertional*
  • Nanog Homeobox Protein / genetics*
  • Pseudogenes

Substances

  • 3' Untranslated Regions
  • Biomarkers, Tumor
  • Culture Media, Conditioned
  • NANOG protein, human
  • Nanog Homeobox Protein

Grants and funding

This work was supported by The Wrenn Trust (grant number 2210-4202), preclinical test of Alzheimer’s disease treatment in human 3D brain in vitro model, Principal Investigator (KS); The Florida Department of Health Ed and Ethel Moore Alzheimer's Disease Research (grant number 6901-7005), Antibody targeting of IL1RAP and studying their therapeutic effects in mouse models of Alzheimer’s disease, Principal Investigator, (KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.